These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31996596)

  • 1. Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or 'PIP' (postexposure prophylaxis in-pocket).
    Wood BR
    AIDS; 2020 Mar; 34(3):481-482. PubMed ID: 31996596
    [No Abstract]   [Full Text] [Related]  

  • 2. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
    Jain S; Krakower DS; Mayer KH
    Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV postexposure prophylaxis-in-pocket: long-term follow-up of individuals with low-frequency, high-risk HIV exposures.
    Alghamdi A; Hempel A; Heendeniya A; Clifford-Rashotte M; Tan DHS; Bogoch II
    AIDS; 2020 Mar; 34(3):433-437. PubMed ID: 31996594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief Report: HIV Postexposure Prophylaxis-in-Pocket ("PIP") for Individuals With Low-Frequency, High-Risk HIV Exposures.
    Tumarkin E; Heendeniya A; Murphy P; Placido T; Tan DHS; Bogoch II
    J Acquir Immune Defic Syndr; 2018 May; 78(1):20-22. PubMed ID: 29419570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief Report: Outcomes of Individuals Using HIV Postexposure Prophylaxis-In-Pocket ("PIP") for Low-Frequency, High-Risk Exposures in Toronto, Canada.
    Billick MJ; Fisher KN; Myers S; Tan DHS; Bogoch II
    J Acquir Immune Defic Syndr; 2023 Nov; 94(3):211-213. PubMed ID: 37850980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing adherence to preexposure and postexposure prophylaxis: the need for an integrated biobehavioral approach.
    Blashill AJ; Ehlinger PP; Mayer KH; Safren SA
    Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S187-90. PubMed ID: 25972502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.
    Heendeniya A; Bogoch II
    Infect Dis Clin North Am; 2019 Sep; 33(3):629-646. PubMed ID: 31239092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Scoping Review of the Current Landscape of Pre-Exposure Prophylaxis and Postexposure Prophylaxis in India.
    Goswami S; Borate S; Marupuru S; Marupuru S
    AIDS Patient Care STDS; 2024 Jul; 38(7):287-304. PubMed ID: 38800957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil.
    Grangeiro A; Couto MT; Peres MF; Luiz O; Zucchi EM; de Castilho EA; Estevam DL; Alencar R; Wolffenbüttel K; Escuder MM; Calazans G; Ferraz D; Arruda É; Corrêa Mda G; Amaral FR; Santos JC; Alvarez VS; Kietzmann T
    BMJ Open; 2015 Aug; 5(8):e009021. PubMed ID: 26307622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in Awareness of HIV Postexposure and Preexposure Prophylaxis Among Notified Partners of HIV-Positive Individuals, New York City 2015-2017.
    Misra K; Udeagu CC
    J Acquir Immune Defic Syndr; 2017 Oct; 76(2):132-140. PubMed ID: 28902677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlapping HIV prevention strategies; case report of pre-exposure and postexposure prophylaxes used for a single risk event between two men.
    Smith DE; Gardiner J; Oliver R; Fagan D
    Sex Transm Infect; 2017 Jun; 93(4):238-239. PubMed ID: 25795661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoprevention of Human Immunodeficiency Virus Infection.
    Yingling C; Broholm C; Stephenson S
    Nurs Clin North Am; 2020 Sep; 55(3):429-444. PubMed ID: 32762861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-exposure and postexposure prophylaxis access in rural versus urban pharmacies in Georgia and Pennsylvania.
    Kislovskiy Y; Pino N; Crawford ND; Woitas T; Cason S; Konka A; Kimble T; Olson I; Villarreal D; Jarlenski M
    J Am Pharm Assoc (2003); 2024; 64(4):102084. PubMed ID: 38574992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A behavioral economics approach to enhancing HIV preexposure and postexposure prophylaxis implementation.
    Li J; Liu Y; Nehl E; Tucker JD
    Curr Opin HIV AIDS; 2024 Jul; 19(4):212-220. PubMed ID: 38686773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Strategic Use of Antiretrovirals to Prevent HIV Infection: A Converging Agenda.
    Baggaley R; Doherty M; Ball A; Ford N; Hirnschall G
    Clin Infect Dis; 2015 Jun; 60 Suppl 3():S159-60. PubMed ID: 25972496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV prevention with postexposure prophylaxis-in-pocket (PIP).
    Billick MJ; Sheps J; Bogoch II
    BMJ; 2023 Aug; 382():e076016. PubMed ID: 37532280
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV Pre-Exposure Prophylaxis and Postexposure Prophylaxis in Japan: Context of Use and Directions for Future Research and Action.
    DiStefano AS; Takeda M
    AIDS Patient Care STDS; 2017 Feb; 31(2):60-77. PubMed ID: 28170304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate usage of post-exposure prophylaxis-in-pocket for HIV prevention by individuals with low-frequency exposures.
    Clifford Rashotte M; Yoong D; Naccarato M; Pico Espinosa OJ; Fisher K; Bogoch II; Tan DH
    Int J STD AIDS; 2024 May; 35(6):446-451. PubMed ID: 37963270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.
    Tan DHS; Hull MW; Yoong D; Tremblay C; O'Byrne P; Thomas R; Kille J; Baril JG; Cox J; Giguere P; Harris M; Hughes C; MacPherson P; O'Donnell S; Reimer J; Singh A; Barrett L; Bogoch I; Jollimore J; Lambert G; Lebouche B; Metz G; Rogers T; Shafran S;
    CMAJ; 2017 Nov; 189(47):E1448-E1458. PubMed ID: 29180384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.